Er. Tamm et P. Russell, The role of myocilin/TIGR in glaucoma: Results of the Glaucoma Research Foundation Catalyst Meeting in Berkeley, California, March 2000, J GLAUCOMA, 10(4), 2001, pp. 329-339
Approximately 3 years ago, the first major (biochemical, molecular biologic
, and biologic) insight into primary open-angle glaucoma was the finding th
at mutations in the myocilin (MYOC/TIGR) gene were related to certain forms
of juvenile onset of this disease. Since then, a great deal of work has be
en done to determine the possible mechanisms by which MYOC/TIGR might cause
not only juvenile but also adult-onset primary open-angle glaucoma. To ass
ess the current knowledge and those areas in which more research is necessa
ry, a meeting of scientists was held by the Glaucoma Research Foundation of
San Francisco, California in the spring of 2000. This meeting attempted to
concentrate on the MYOC/TIGR protein rather than the genetics of this gene
. Possible functions and roles of this protein intracellularly and extracel
lularly were critically examined and discussed. Normal transcriptional and
translational events and the effect of mutations on these events were explo
red. The discussions yielded insight not only in those areas in which impor
tant information is known but also in vital areas in which little is curren
tly understood. This review attempts to summarize the current knowledge reg
arding MYOC/TIGR and to elucidate the points that the people attending the
meeting thought needed further study.